Company Filing History:
Years Active: 2022-2023
Title: Tara Neville: Innovator in Microbiota Dysbiosis Treatment
Introduction
Tara Neville is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of microbiota research, particularly in the prevention and treatment of microbiota dysbiosis in young mammals. With a total of 2 patents, her work addresses critical health issues that can arise from imbalances in gut microbiota.
Latest Patents
Tara Neville's latest patents focus on the use of specific treatments for microbiota dysbiosis. The inventions aim to prevent or treat conditions associated with decreased levels of Actinobacteria and increased levels of Proteobacteria in young mammals. These conditions can be caused by various factors, including caesarean section births, antibiotic exposure, and gastrointestinal dysfunctions. The disorders that may be treated or prevented include infections, allergies, type I diabetes mellitus, insulin resistance, obesity, and inflammatory bowel diseases, among others.
Career Highlights
Tara Neville is currently associated with Biogaia AB, a company dedicated to developing innovative solutions for gut health. Her research has been instrumental in advancing our understanding of microbiota dysbiosis and its implications for early life health.
Collaborations
Tara collaborates with notable colleagues, including Clara Lucia Garcia-Rodenas and Bernard Berger. Their combined expertise enhances the research and development efforts at Biogaia AB.
Conclusion
Tara Neville's innovative work in microbiota dysbiosis treatment highlights her commitment to improving health outcomes for young mammals. Her contributions are paving the way for new therapeutic approaches in this vital area of health research.